Gadoversetamide

DB00538

small molecule approved investigational

Deskripsi

Gadoversetamide, marketed under the trade name OptiMARK, is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver.

Struktur Molekul 2D

Berat 661.76
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Distribution 13.3 ± 6.8 (mean) minutes, elimination 103.6 ± 19.5 (mean) minutes.
Volume Distribusi * 162 ± 25 mL/kg [normal subjects]
Klirens (Clearance) * 72 +/- 16.3 mL/hr/kg [healthy]

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

None detected

Rute Eliminasi

The mean cumulative urinary excretion of gadoversetamide at 72 hours was approximately 93.5% for renal impaired patients and 95.8% for subjects with normal renal function

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 20 • International brands: 0
Produk
  • Optimark
    Injection, solution • 0.5 mmol/1mL • Intravenous • US • Approved
  • Optimark
    Solution • 330.9 mg / mL • Intravenous • Canada • Approved
  • Optimark
    Solution • 330.9 mg / mL • Intravenous • Canada • Approved
  • Optimark
    Solution • 330.9 mg / mL • Intravenous • Canada • Approved
  • Optimark
    Solution • 330.9 mg / mL • Intravenous • Canada • Approved
  • Optimark
    Solution • 330.9 mg / mL • Intravenous • Canada • Approved
  • Optimark
    Injection, solution • 500 micromol/ml • Intravenous • EU
  • Optimark
    Injection, solution • 500 micromol/ml • Intravenous • EU
Menampilkan 8 dari 20 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul